Suraksha Diagnostic H1 FY27: revenue up 25.9% to ₹99 Cr, net profit up 69.3% to ₹15 Cr
Results · 12 Nov 2026 · Suraksha Diagnostic (SURAKSHA)
| H1 FY27 | ₹ Cr | YoY |
|---|---|---|
| Revenue | 99 | +25.9% |
| Operating profit | 35 | +44.4% |
| Net profit | 15 | +69.3% |
Suraksha Diagnostic issued a corrigendum on 12 November 2026 to its 10 November press release on Q2 and H1 FY27 results, correcting inadvertent errors in the Key Operational Highlights.
Corrected: Q2 total tests 2.40 million up 9% YoY, tests per patient 5.70 down 2% and average revenue per test Rs 412 up 15%; the enclosed updated release shows Q2 total income Rs 100.58 crore up 26%, EBITDA Rs 36.32 crore up 45% and PAT Rs 14.95 crore up 69% YoY.
Operating margin was 35.1%, up 4.5 pp on a year earlier.
NSE filing (PDF) · Company page · Results tracker
Anand Ganapathy K | SEBI Registered Research Analyst | INH000016630.